Timing of previous hospitalizations impacts outcomes in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009
Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012
The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010
Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009
Etiology and clinical outcome of community-acquired pneumonias in hospitalized children Source: Eur Respir J 2007; 30: Suppl. 51, 398s Year: 2007
Analysis of the mortality caused by community-acquired pneumonia in the elderly Source: Eur Respir J 2005; 26: Suppl. 49, 544s Year: 2005
Criteria for clinical stability in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2013; 42: 742-749 Year: 2013
Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009
Management of community-acquired pneumonia in adult outpatients Source: Eur Respir J 2006; 28: Suppl. 50, 377s Year: 2006
Differential clinical and etiological features in young and elderly patients hospitalized due to community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 354s Year: 2002
Impact of nosocomial pneumonia on the outcome of mechanically-ventilated patients Source: Eur Respir J 2004; 24: Suppl. 48, 548s Year: 2004
Etiology of community-acquired pneumonia (CAP) in young hospital patients Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002
Mixed community-acquired pneumonia in hospitalised patients Source: Eur Respir J 2006; 27: 795-800 Year: 2006
Heliox-therapy of patients with execerbation of COPD and community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 106s Year: 2006
Etiological spectrum of hospitalized community-acquired pneumonia Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host Year: 2007
Analysis of mortality from community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 376s Year: 2006
Peculiarities of community-acquired pneumonia in tobacco-smoking patients Source: Annual Congress 2009 - Tobacco: from smoke to disease Year: 2009
The impact of patients‘ age and concomitant diseases on community-acquired pneumonia outcome Source: Eur Respir J 2007; 30: Suppl. 51, 675s Year: 2007
Hospitalized community-acquired pneumonia in the elderly: etiology and comorbidities Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018
Outpatient treatment of community-acquired pneumonia in the elderly Source: Eur Respir J 2002; 20: Suppl. 38, 355s Year: 2002